Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Beauty Health Co (SKIN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/09/2025: SKIN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $1.66
1 Year Target Price $1.66
| 0 | Strong Buy |
| 0 | Buy |
| 7 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -27.55% | Avg. Invested days 23 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/09/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 264.59M USD | Price to earnings Ratio - | 1Y Target Price 1.66 |
Price to earnings Ratio - | 1Y Target Price 1.66 | ||
Volume (30-day avg) 9 | Beta 1.18 | 52 Weeks Range 0.78 - 2.38 | Updated Date 07/9/2025 |
52 Weeks Range 0.78 - 2.38 | Updated Date 07/9/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.34 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -11.94% | Operating Margin (TTM) -17.28% |
Management Effectiveness
Return on Assets (TTM) -5.17% | Return on Equity (TTM) -70.44% |
Valuation
Trailing PE - | Forward PE 25.51 | Enterprise Value 459244120 | Price to Sales(TTM) 0.82 |
Enterprise Value 459244120 | Price to Sales(TTM) 0.82 | ||
Enterprise Value to Revenue 1.42 | Enterprise Value to EBITDA 125.44 | Shares Outstanding 125994000 | Shares Floating 80810252 |
Shares Outstanding 125994000 | Shares Floating 80810252 | ||
Percent Insiders 10.07 | Percent Institutions 83.89 |
Upturn AI SWOT
Beauty Health Co
Company Overview
History and Background
Beauty Health Co., formerly known as HydraFacial Company, was founded in 2016 and went public in 2021 through a SPAC merger. The company focuses on providing aesthetic and skincare solutions, with its flagship product being the HydraFacial treatment. It has grown through product innovation and strategic partnerships, establishing itself as a key player in the aesthetic devices market.
Core Business Areas
- HydraFacial: The HydraFacial segment focuses on the manufacturing and distribution of the HydraFacial device and related consumables. This includes serums, tips, and other skincare products used in conjunction with the device.
- Consumer: This segment encompasses the company's consumer-facing skincare product lines, aimed at extending the benefits of HydraFacial treatments at home.
Leadership and Structure
Beauty Health Co.'s leadership team consists of experienced executives in the medical device and consumer beauty industries. The organizational structure is designed to support both its professional and consumer product lines, with dedicated teams for sales, marketing, research and development, and operations.
Top Products and Market Share
Key Offerings
- HydraFacial System: The HydraFacial system is a multi-step facial treatment using a patented device. It cleanses, exfoliates, extracts, and hydrates the skin. Market share data is difficult to pinpoint precisely, but HydraFacial is a leading brand in professional aesthetics. Competitors include SilkPeel Dermalinfusion, microdermabrasion systems, and other facial treatment devices. Revenue figures are closely guarded, but Hydrafacial represents the company's main revenue stream.
- At-Home Skincare Products: Beauty Health Co. offers a range of skincare products designed for at-home use to complement HydraFacial treatments. Market share data is less readily available for these products specifically. Competitors include other professional skincare brands and mass-market skincare lines.
Market Dynamics
Industry Overview
The aesthetic devices market is experiencing strong growth, driven by increasing demand for non-invasive cosmetic procedures. Technological advancements and a growing awareness of skincare are fueling market expansion.
Positioning
Beauty Health Co. is positioned as a premium provider of aesthetic skincare solutions. Its HydraFacial system is known for its unique technology and effective results. The company benefits from brand recognition and a strong network of aesthetic professionals.
Total Addressable Market (TAM)
The global aesthetic medicine market is expected to reach hundreds of billions of dollars in the coming years. Beauty Health Co. is well-positioned to capture a portion of this TAM, given its established brand and expanding product portfolio. TAM is expected to be over 300 billion by 2030. Beauty Health is focusing on growing its market share in the esthetic field through the Hydrafacial system.
Upturn SWOT Analysis
Strengths
- Strong Brand Recognition
- Patented Technology
- Established Professional Network
- Recurring Revenue Model (Consumables)
Weaknesses
- High Dependence on HydraFacial System
- Premium Pricing May Limit Market Reach
- Vulnerable to Imitation Products
- Potential for Supply Chain Disruptions
Opportunities
- Expansion into New Geographic Markets
- Development of New Skincare Products
- Strategic Partnerships with Medspas and Clinics
- Increased Focus on Consumer Skincare
Threats
- Intense Competition from Other Aesthetic Device Companies
- Economic Downturn Could Reduce Consumer Spending
- Changes in Regulations Regarding Aesthetic Procedures
- Emergence of New Technologies
Competitors and Market Share
Key Competitors
- InMode Ltd. (INMD)
- Cutera, Inc. (CUTR)
- Alma Lasers
Competitive Landscape
Beauty Health Co. competes on brand recognition, technology, and a network of professionals. INMD and CUTR and Alma Lasers are all competing by introducing different technologies, new features, and marketing innovations.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been influenced by product innovation and expansion. Refer to financial statements for accurate trends.
Future Projections: Analyst estimates vary, but project a growth trajectory based on market trends. Please refer to financial news and analyst reports for projections.
Recent Initiatives: Recent initiatives include strategic partnerships and new product launches.
Summary
Beauty Health Co. is a prominent player in the aesthetic skincare market, driven by its flagship HydraFacial system. The company's strengths lie in its brand recognition and technology. However, it faces challenges related to market competition and economic uncertainties. Continued innovation and expansion are crucial for sustained growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Financial News Outlets
- Analyst Reports
Disclaimers:
This analysis is based on available information and is not financial advice. Market conditions and company performance are subject to change. Consult a financial professional before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Beauty Health Co
Exchange NASDAQ | Headquaters Long Beach, CA, United States | ||
IPO Launch date 2020-11-24 | President, CEO & Director Ms. Marla Malcolm Beck | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 769 | Website https://www.beautyhealth.com |
Full time employees 769 | Website https://www.beautyhealth.com | ||
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.